INFLIXIMAB (systemic) is used in: (A) Crohn's disease (treatment), (B) To reduce the number of draining enterocutaneous fistula(s) in patients with fistuLizing crohn's disease, (C) Rheumatoid arthritis (treatment), (D) All of the above
Answer is D. None